Who owns NEWAMSTERDAM PHARMA CO NV?
- Ticker: NAMS
- CUSIP Number: n62509109
Tip: Access positions for across all investors
Analyze quarterly positions in Newamsterdam Pharma Co Nv with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Newamsterdam Pharma Co Nv stock
Who bought or sold NEWAMSTERDAM PHARMA CO NV this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Frazier Life Sciences Management | 12M | $136M | 0% | Dec 2023 |
|
Fcpm Iii Services B.v. | 12M | $132M | 100% | Dec 2023 |
|
Bain Capital Life Sciences Investors | 11M | $97M | 0% | Sep 2023 |
|
Viking Global Investors | 8.0M | $90M | 0% | Dec 2023 |
|
RA Capital Management | 7.9M | $88M | -13% | Dec 2023 |
|
Medicxi Ventures Management | 2.9M | $32M | 0% | Dec 2023 |
|
BVF | 1.5M | $17M | 0% | Dec 2023 |
|
Goldman Sachs Group | 1.4M | $16M | 100% | Dec 2023 |
|
GMT Capital Corp | 1.4M | $16M | 0% | Dec 2023 |
|
Millennium Management | 1.3M | $15M | 27% | Dec 2023 |
|
Adage Capital Partners GP | 1.2M | $11M | 0% | Sep 2023 |
|
Eversept Partners | 661k | $6.1M | -5% | Sep 2023 |
|
Ensign Peak Advisors | 438k | $4.0M | -1% | Sep 2023 |
|
Alyeska Investment Group | 289k | $3.2M | -13% | Dec 2023 |
|
Axa | 283k | $2.6M | 26% | Sep 2023 |
|
Opaleye Management | 265k | $3.0M | 100% | Dec 2023 |
|
Parkman Healthcare Partners | 249k | $2.3M | 4% | Sep 2023 |
|
Affinity Asset Advisors | 125k | $1.2M | 25% | Sep 2023 |
|
Schonfeld Strategic Advisors | 67k | $747k | 3% | Dec 2023 |
|
UBS O'Connor | 45k | $416k | 100% | Sep 2023 |
|
Geode Capital Management | 42k | $387k | 62% | Sep 2023 |
|
Marshall Wace | 34k | $379k | 234% | Dec 2023 |
|
BlackRock | 23k | $212k | 100% | Sep 2023 |
|
Citadel Advisors | 21k | $235k | -33% | Dec 2023 |
|
Atlantic Trust | 13k | $120k | 100% | Sep 2023 |
|
Royal Bank of Canada | 11k | $121k | 988% | Dec 2023 |
|
Venture Visionary Partners | 10k | $112k | 0% | Dec 2023 |
|
Wolverine Asset Management | 8.7k | $97k | 197% | Dec 2023 |
|
Morgan Stanley | 1.7k | $16k | 111% | Sep 2023 |
|
UBS Group | 800.00 | $8.9k | 100% | Dec 2023 |
|
Barclays | 513.00 | $6.0k | 0% | Dec 2023 |
|
Cutler | 500.00 | $5.0k | 0% | Dec 2023 |
|
Wells Fargo & Company | 300.00 | $3.4k | 0% | Dec 2023 |
|
Atticus Wealth Management | 100.00 | $1.1k | 0% | Dec 2023 |
|
DuPont Capital Management Corporation | 1.00 | $11.000000 | 0% | Dec 2023 |
|
Who sold out of Newamsterdam Pharma Co Nv?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Henderson Group | Sep 2023 | 435k | $4.0M |
Maven Securities | Sep 2023 | 25k | $231k |
Parkwood | Sep 2023 | 20k | $187k |
Jpmorgan Chase & Co | Sep 2023 | 2.6k | $24k |